These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6143817

  • 1. Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526.
    Ohlstein EH, Zabko-Potapovich B, Berkowitz BA.
    J Pharmacol Exp Ther; 1984 May; 229(2):433-9. PubMed ID: 6143817
    [Abstract] [Full Text] [Related]

  • 2. Effects of SK&F 82526 and SK&F 83742 on the renal vascular dopamine receptor.
    Schmidt M, Imbs JL, Giesen-Crouse EM, Schwartz J.
    J Pharmacol; 1985 May; 16(1):15-22. PubMed ID: 2582206
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptor.
    Berkowitz BA, Ohlstein EH.
    J Cardiovasc Pharmacol; 1984 May; 6 Suppl 4():S559-63. PubMed ID: 6210423
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA, Wardell JR, Sarau HM, Ridley PT.
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [Abstract] [Full Text] [Related]

  • 5. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC, Lawson K, Thiry C, Cavero I.
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [Abstract] [Full Text] [Related]

  • 6. Alpha-adrenoceptor blocking activity of fenoldopam (SK&F 82526), a selective DA1 agonist.
    Nakamura S, Kohli JD, Rajfer SI.
    J Pharm Pharmacol; 1986 Feb; 38(2):113-7. PubMed ID: 2870153
    [Abstract] [Full Text] [Related]

  • 7. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.
    Kerns WD, Arena E, Morgan DG.
    Am J Pathol; 1989 Aug; 135(2):339-49. PubMed ID: 2571297
    [Abstract] [Full Text] [Related]

  • 8. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ, Fujita T, Smith JM, Kopaciewicz LJ, Blumberg AL, Hieble JP.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ, Smith JM, Shebuski RJ, Ruffolo RR.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [Abstract] [Full Text] [Related]

  • 10. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
    Kinter LB, Mann WA, Weinstock J, Ruffolo RR.
    Chirality; 1994 Aug; 6(5):446-55. PubMed ID: 7915128
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
    Kinter LB, Horner E, Mann WA, Weinstock J, Ruffolo RR.
    Chirality; 1990 Aug; 2(4):219-25. PubMed ID: 1982058
    [Abstract] [Full Text] [Related]

  • 12. Neuroinhibitory effects of SK&F 85174, a novel dopamine receptor agonist.
    Blumberg AL, Wilson JW, Hieble JP.
    J Cardiovasc Pharmacol; 1985 Aug; 7(4):723-32. PubMed ID: 2410714
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological evidence for the presence of a peripheral postjunctional D2-like dopamine receptor in rabbit splenic artery.
    Zanzottera D, Ferlenga P, Marchini F, Semeraro C.
    Br J Pharmacol; 1998 Feb; 123(4):730-6. PubMed ID: 9517393
    [Abstract] [Full Text] [Related]

  • 14. Dopamine receptors in human basilar arteries.
    Forster C, Drew GM, Hilditch A, Whalley ET.
    Eur J Pharmacol; 1983 Feb 18; 87(2-3):227-35. PubMed ID: 6573262
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM.
    Eur J Pharmacol; 1986 Jul 15; 126(1-2):167-70. PubMed ID: 2875883
    [Abstract] [Full Text] [Related]

  • 16. SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors.
    Ohlstein EH, Berkowitz BA.
    Eur J Pharmacol; 1985 Jan 22; 108(2):205-8. PubMed ID: 3884345
    [Abstract] [Full Text] [Related]

  • 17. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S, Lee J, Kiguchi M, Uchida T, Cools AR, Waddington JL, Koshikawa N.
    Eur J Pharmacol; 2006 May 24; 538(1-3):94-100. PubMed ID: 16682023
    [Abstract] [Full Text] [Related]

  • 18. (3,4-Dihydroxybenzyl)-2-imidazoline (DHBI): an analogue of dopamine.
    O'Donnell JP, Azzaro AJ, Urquilla PR.
    Res Commun Chem Pathol Pharmacol; 1979 Nov 24; 26(2):243-51. PubMed ID: 230552
    [Abstract] [Full Text] [Related]

  • 19. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
    Grega GJ, Barrett RJ, Adamski SW, Lokhandwala MF.
    J Pharmacol Exp Ther; 1984 Jun 24; 229(3):756-62. PubMed ID: 6144791
    [Abstract] [Full Text] [Related]

  • 20. Peripheral dopamine receptor blockade by SCH 23390 and domperidone in vitro.
    Hilditch A, Drew GM.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):171-4. PubMed ID: 2865160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.